Monday, 5 October 2026European Markets

OENEO And 2 Other Stocks Have Very High Payout Ratio

Loading stream...

(vianews) - veidekke (vei.ol), oeneo (sbt.pa), irish cont. gp. (ir5b.ir) are the highest payout ratio stocks on this list.

we have gathered information about stocks with the highest payout ratio up until now. the payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.

when investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.

1. veidekke (vei.ol)

86.42% payout ratio

veidekke asa operates as a construction and property development company. it operates through construction norway, infrastructure norway, construction sweden, infrastructure sweden, and denmark/hoffmann segments. the company operates as a construction contractor; executes civil engineering and renovation projects; and produces asphalt and aggregates, as well as operates in the public road maintenance market. it is also involved in the civil engineering, recycling, and asphalting projects, as well as constructs commercial and residential buildings. veidekke asa was founded in 1936 and is headquartered in oslo, norway.

earnings per share

as for profitability, veidekke has a trailing twelve months eps of kr8.13.

pe ratio

veidekke has a trailing twelve months price to earnings ratio of 13.43. meaning, the purchaser of the share is investing kr13.43 for every norwegian krone of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 37.83%.

earnings before interest, taxes, depreciation, and amortization

veidekke's ebitda is 0.31.

yearly top and bottom value

veidekke's stock is valued at kr109.20 at 07:10 est, way below its 52-week high of kr122.80 and way higher than its 52-week low of kr80.90.

moving average

veidekke's value is below its 50-day moving average of kr110.77 and above its 200-day moving average of kr101.05.

growth estimates quarters

the company's growth estimates for the ongoing quarter and the next is 30.5% and 2.2%, respectively.

more news about veidekke.

2. oeneo (sbt.pa)

47.62% payout ratio

oeneo sa operates in the wine industry worldwide. the company manufactures and sale of cork closures. it also provides solutions in wine making and spirits. oeneo sa is headquartered in bordeaux, france. oeneo sa is a subsidiary of caspar sas.

earnings per share

as for profitability, oeneo has a trailing twelve months eps of €0.63.

pe ratio

oeneo has a trailing twelve months price to earnings ratio of 22.94. meaning, the purchaser of the share is investing €22.94 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.71%.

moving average

oeneo's value is above its 50-day moving average of €14.02 and above its 200-day moving average of €14.42.

volume

today's last reported volume for oeneo is 135 which is 97.37% below its average volume of 5151.

more news about oeneo.

3. irish cont. gp. (ir5b.ir)

41.08% payout ratio

irish continental group plc operates as a maritime transport company. it operates through two segments, ferries, and container and terminal. the ferries segment engages in the provision of passenger and roll on roll off freight shipping, and container lift on lift off (lolo) freight services on routes between ireland, britain, and continental europe. the container and terminal segment provides door-to-door and feeder lolo freight services, stevedoring, and other related terminal services, as well as operates container terminals in the ports of dublin and belfast. the company also provides container shipping, ship leasing, administration, and container handling services. in addition, it operates ferry; and act as a shipping and forwarding agency. the company was founded in 1972 and is based in dublin, ireland.

earnings per share

as for profitability, irish cont. gp. has a trailing twelve months eps of €0.34.

pe ratio

irish cont. gp. has a trailing twelve months price to earnings ratio of 13.29. meaning, the purchaser of the share is investing €13.29 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.43%.

moving average

irish cont. gp.'s worth is below its 50-day moving average of €4.53 and above its 200-day moving average of €4.30.

yearly top and bottom value

irish cont. gp.'s stock is valued at €4.52 at 07:10 est, under its 52-week high of €4.80 and way above its 52-week low of €3.35.

dividend yield

according to morningstar, inc., the next dividend payment is on may 18, 2023, the estimated forward annual dividend rate is 0.14 and the estimated forward annual dividend yield is 3.02%.

more news about irish cont. gp..

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com